Oliveira S H P, Costa C H S, Ferreira S H, Cunha F Q
Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of Sao Paulo, Brazil.
Inflamm Res. 2002 Mar;51(3):144-53. doi: 10.1007/pl00000286.
In this study we investigated the chemotactic mediators involved in the Sephadex-induced eosinophil migration into the peritoneal cavities of rats and mice, and which resident peritoneal cells release these mediators.
Sephadex suspension was injected into the peritoneal cavities of rats or mice which were pretreated, or not, with specific drugs that inhibit synthesis or production of the inflammatory mediators and eosinophil chemotactic activities were observed. To investigate the role of resident peritoneal cells as a source of these chemotactic factors, the macrophage population was enhanced or the mast cell population was depleted. The resident cells were also stimulated, in vitro, with Sephadex and the chemotactic activity of the supernatants was determined.
Sephadex induced dose and time dependent eosinophil migration in rats and mouse, which were inhibited by dexamethasone and MK 886. BN 52021 only affected the eosinophil migration into the mouse peritoneal cavity. An increase in the macrophage population did not alter the eosinophil migration induced by Sephadex in rat or mouse. However, mast cell population depletion reduced eosinophil migration in rats, but did not alter the migration in mice. Sephadex-stimulated rat mast cells released an eosinophil chemotactic factor whose release was inhibited by dexamethasone and MK 886. Anti-TNF-alpha and anti-IL-8 Abs inhibited the chemotactic activity of the mast cell supernatant.
Sephadex-induced eosinophil migration into the rat peritoneal cavity is dependent on mast cells, which release LTB4, TNF-alpha and CINC-1. Conversely, Sephadex-induced eosinophil migration into the mouse peritoneal cavity is mediated by PAF and LTB4, which are not released from resident macrophages or mast cells.
在本研究中,我们调查了参与葡聚糖诱导嗜酸性粒细胞迁移至大鼠和小鼠腹腔的趋化介质,以及哪些腹腔常驻细胞释放这些介质。
将葡聚糖悬液注入经或未经抑制炎症介质合成或产生的特定药物预处理的大鼠或小鼠腹腔,并观察嗜酸性粒细胞趋化活性。为研究腹腔常驻细胞作为这些趋化因子来源的作用,增强巨噬细胞群体或减少肥大细胞群体。还在体外用葡聚糖刺激常驻细胞,并测定上清液的趋化活性。
葡聚糖在大鼠和小鼠中诱导剂量和时间依赖性的嗜酸性粒细胞迁移,地塞米松和MK 886可抑制这种迁移。BN 52021仅影响嗜酸性粒细胞向小鼠腹腔的迁移。巨噬细胞群体增加并未改变葡聚糖在大鼠或小鼠中诱导的嗜酸性粒细胞迁移。然而,肥大细胞群体减少可降低大鼠中的嗜酸性粒细胞迁移,但不改变小鼠中的迁移。葡聚糖刺激的大鼠肥大细胞释放一种嗜酸性粒细胞趋化因子,其释放受到地塞米松和MK 886的抑制。抗TNF-α和抗IL-8抗体抑制肥大细胞上清液的趋化活性。
葡聚糖诱导嗜酸性粒细胞迁移至大鼠腹腔依赖于肥大细胞,肥大细胞释放白三烯B4、TNF-α和CINC-1。相反,葡聚糖诱导嗜酸性粒细胞迁移至小鼠腹腔由血小板活化因子和白三烯B4介导,它们并非由常驻巨噬细胞或肥大细胞释放。